Effects of synaptic modulation on β-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice
Tampellini, Davide LU ; Capetillo-Zarate, Estibaliz ; Dumont, Magali ; Huang, Zhenyong ; Yu, Fangmin ; Lin, Michael T. and Gouras, Gunnar K. LU
(2010)
In The Journal of Neuroscience
30(43).
p.14299-14304
- Abstract
Accumulation of β-amyloid (Aβ) and loss of synapses are hallmarks of Alzheimer's disease (AD). How synaptic activity relates to Aβ accumulation and loss of synapses is a current topic of major interest. Synaptic activation promotes Aβ secretion, and chronic reduction of synaptic activity reduced Aβ plaques in an AD transgenic mouse model. This suggested beneficial effects of reducing synaptic activity in AD. We now show that reduced synaptic activity causes detrimental effects on synapses and memory despite reducing plaques using two different models of chronic synaptic inhibition: deafferentation of the barrel cortex and administration of benzodiazepine. An interval of prolonged synaptic inhibition exacerbated loss of synaptophysin... (More)
Accumulation of β-amyloid (Aβ) and loss of synapses are hallmarks of Alzheimer's disease (AD). How synaptic activity relates to Aβ accumulation and loss of synapses is a current topic of major interest. Synaptic activation promotes Aβ secretion, and chronic reduction of synaptic activity reduced Aβ plaques in an AD transgenic mouse model. This suggested beneficial effects of reducing synaptic activity in AD. We now show that reduced synaptic activity causes detrimental effects on synapses and memory despite reducing plaques using two different models of chronic synaptic inhibition: deafferentation of the barrel cortex and administration of benzodiazepine. An interval of prolonged synaptic inhibition exacerbated loss of synaptophysin compared with synaptically more active brain in AD transgenic but not wild-type mice. Furthermore, an interval of benzodiazepine treatment, followed by a washout period, exacerbated memory impairment in AD transgenic mice. Exacerbation of synaptic and behavioral abnormalities occurred in the setting of reduced Aβ plaques but elevated intraneuronal Aβ immunoreactivity. These data support beneficial effects of synaptic activation on Aβ-related synaptic and behavioral impairment in AD.
(Less)
- author
- Tampellini, Davide
LU
; Capetillo-Zarate, Estibaliz
; Dumont, Magali
; Huang, Zhenyong
; Yu, Fangmin
; Lin, Michael T.
and Gouras, Gunnar K.
LU
- publishing date
- 2010-10-27
- type
- Contribution to journal
- publication status
- published
- subject
- in
- The Journal of Neuroscience
- volume
- 30
- issue
- 43
- pages
- 14299 - 14304
- publisher
- Society for Neuroscience
- external identifiers
-
- scopus:78049349176
- pmid:20980585
- ISSN
- 0270-6474
- DOI
- 10.1523/JNEUROSCI.3383-10.2010
- language
- English
- LU publication?
- no
- id
- 1e77c251-71a3-4ac0-b8b8-9acaad34dbd4
- date added to LUP
- 2020-02-20 14:16:29
- date last changed
- 2024-05-30 12:11:58
@article{1e77c251-71a3-4ac0-b8b8-9acaad34dbd4,
abstract = {{<p>Accumulation of β-amyloid (Aβ) and loss of synapses are hallmarks of Alzheimer's disease (AD). How synaptic activity relates to Aβ accumulation and loss of synapses is a current topic of major interest. Synaptic activation promotes Aβ secretion, and chronic reduction of synaptic activity reduced Aβ plaques in an AD transgenic mouse model. This suggested beneficial effects of reducing synaptic activity in AD. We now show that reduced synaptic activity causes detrimental effects on synapses and memory despite reducing plaques using two different models of chronic synaptic inhibition: deafferentation of the barrel cortex and administration of benzodiazepine. An interval of prolonged synaptic inhibition exacerbated loss of synaptophysin compared with synaptically more active brain in AD transgenic but not wild-type mice. Furthermore, an interval of benzodiazepine treatment, followed by a washout period, exacerbated memory impairment in AD transgenic mice. Exacerbation of synaptic and behavioral abnormalities occurred in the setting of reduced Aβ plaques but elevated intraneuronal Aβ immunoreactivity. These data support beneficial effects of synaptic activation on Aβ-related synaptic and behavioral impairment in AD.</p>}},
author = {{Tampellini, Davide and Capetillo-Zarate, Estibaliz and Dumont, Magali and Huang, Zhenyong and Yu, Fangmin and Lin, Michael T. and Gouras, Gunnar K.}},
issn = {{0270-6474}},
language = {{eng}},
month = {{10}},
number = {{43}},
pages = {{14299--14304}},
publisher = {{Society for Neuroscience}},
series = {{The Journal of Neuroscience}},
title = {{Effects of synaptic modulation on β-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice}},
url = {{http://dx.doi.org/10.1523/JNEUROSCI.3383-10.2010}},
doi = {{10.1523/JNEUROSCI.3383-10.2010}},
volume = {{30}},
year = {{2010}},
}